The Food and Drug Administration warned Houston-based Empower Pharmacy on Sept. 18, 2025, that it violated federal law by mass-producing unauthorized copies of blockbuster weight-loss drugs. The warning letter, posted online Tuesday, marks the first time federal regulators have intervened in the ongoing debate over where personalized pharmacy compounding ends and illegal mass-manufacturing begins. FDA … Read more
According to the U.S. Food and Drug Administration, a nationwide recall of generic dabigatran etexilate blood thinner products distributed by Major Pharmaceuticals is not expected to cause serious health harm. The federal agency classified the action as a Class III recall on August 5, indicating its lowest risk level after testing at the 12-month storage … Read more
Colorado has secured federal authorization to import lower-cost prescription drugs from Canada, a move state officials estimate could save residents approximately $46 million on 20 common medications over three years. However, the program faces significant logistical hurdles, including Canadian export restrictions and private manufacturing contracts that currently prevent the sale of these drugs to the … Read more
The Hidden Risks in Your Supplement Cabinet: Why Quality Control is Facing a Reckoning When you reach for a bottle of green superfood capsules, you’re likely looking to optimize your health, not jeopardize it. Yet, the recent nationwide recall of TNVitamins and Doctor’s Pride Moringa capsules due to potential salmonella contamination highlights a jarring reality: … Read more
The Shifting Landscape of Mental Health: Is Psychiatry at an Inflection Point? For decades, the annual meeting of the American Psychiatric Association (APA) has been a fortress of clinical consensus. But this year, the atmosphere was palpably different. Just days after the Department of Health and Human Services (HHS) announced a federal push to address … Read more
The Tug-of-War Between Science and Political Mandates The recent upheaval at the Food and Drug Administration (FDA) highlights a growing global trend: the increasing tension between non-partisan scientific rigor and executive political agendas. When regulatory bodies become battlegrounds for ideological conflicts—ranging from the approval of flavored vapes to the scrutiny of abortion medications—the primary casualty … Read more
The Price of Longevity: How Wealth is Shaping the Future of Healthspan The pursuit of a longer, healthier life is as old as humanity itself. But today, that pursuit is increasingly stratified, with access to cutting-edge preventative care and wellness solutions heavily influenced by financial resources. From concierge medicine to a booming supplement industry, a … Read more
The Future of Supplement Safety: Navigating a Changing Landscape Seventy-four percent of adults now take a vitamin, mineral, herb, or botanical, fueling a $69 billion market. Yet, unlike pharmaceuticals, dietary supplements aren’t subject to pre-market approval by the Food and Drug Administration (FDA). This means manufacturers aren’t required to prove safety, effectiveness, or even accurate … Read more
Children’s Ibuprofen Recall: A Sign of Growing Concerns in Pharmaceutical Supply Chains? Nearly 90,000 bottles of Children’s Ibuprofen Oral Suspension have been voluntarily recalled by Taro Pharmaceuticals due to reports of contaminants – specifically, “a gel-like mass and black particles” – prompting questions about quality control and the complexities of global pharmaceutical manufacturing. The Details … Read more
FDA Scrutiny of Ozempic: A Sign of Increased Oversight for Weight Loss Drugs? Novo Nordisk, the maker of the popular diabetes and weight loss drug Ozempic, is facing renewed scrutiny from the U.S. Food and Drug Administration (FDA). A warning letter issued on March 5th highlighted concerns over the company’s reporting procedures for potential side … Read more